Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer

被引:164
|
作者
Patz, EF
Rossi, S
Harpole, DH
Herndon, JE
Goodman, PC
机构
[1] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Thorac Surg, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Div Biometry Community & Family Med, Durham, NC 27710 USA
关键词
lung cancer; lung cancer screening; pulmonary nodules;
D O I
10.1378/chest.117.6.1568
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The purpose of this study was to determine the relationship between tumor size and survival in patients with state IA non-small cell lung cancer (non-small cell lung cancer; ie, lesions < 3 cm). Method: Five hundred ten patients with pathologic stage IA (T1N0M0) non-small cell lung cancer were identified from our tumor registry over an 18-year period (from 1981 to 1999). There were 285 men and 225 women, with a mean age of 63 years (range, 31 to 90 years). The Cox proportional model was used to examine the effect on survival. Tumor size was incorporated into the model as a linear effect and as categorial variables. The Kaplan-Meier product limit estimator was used to graphically display the relationship between the tumor size and survival. Results: The Cox proportional hazards model did not show a statistically significant relationship between tumor size and survival (p = 0.701) as a linear effect. Tumor size was then categorized into quartiles, and again there was no statistically significant difference in survival between groups (p = 0.597). Tumor size was also categorized into deciles, and there was no statistical relationship between tumor size and survival (p = 0.674). Conclusions: This study confirms stratifying patients with stage IA non-small cell lung cancer in the same TNM classification, given no apparent difference in survival. Unfortunately, these data caution that improved small nodule detection with screening CT may not significantly improve lung cancer mortality. The appropriate prospective randomized trial appears warranted.
引用
收藏
页码:1568 / 1571
页数:4
相关论文
共 50 条
  • [1] Unexpected observations on tumor size and survival in stage IA non-small cell lung cancer
    Black, WC
    [J]. CHEST, 2000, 117 (06) : 1532 - 1534
  • [2] Tumor size predicts survival within stage IA non-small cell lung cancer
    Port, JL
    Kent, MS
    Korst, RJ
    Libby, D
    Pasmantier, M
    Altorki, NK
    [J]. CHEST, 2003, 124 (05) : 1828 - 1833
  • [3] Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease
    Gajra, A
    Newman, N
    Gamble, GP
    Abraham, NZ
    Kohman, LJ
    Graziano, SL
    [J]. LUNG CANCER, 2003, 42 (01) : 51 - 57
  • [4] Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21-30 mm
    Yu, Xiangyang
    Zhang, Rusi
    Zhang, Mengqi
    Lin, Yongbin
    Zhang, Xuewen
    Wen, Yingsheng
    Yang, Longjun
    Huang, Zirui
    Wang, Gongming
    Zhao, Dechang
    Gonzalez, Michel
    Baste, Jean-Marc
    Petersen, Rene Horsleben
    Ng, Calvin S. H.
    Brunelli, Alessandro
    Zheng, Lie
    Zhang, Lanjun
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (02) : 900 - 913
  • [5] Nomogram to Predict Cancer Specific Survival in Patients with Pathological Stage IA Non-small Cell Lung Cancer
    Cai, Jing-Sheng
    Dou, Xiao-Meng
    Li, Ji-Bin
    Yang, Mu-Zi
    Xie, Chu-Long
    Hou, Xue
    Yang, Hao-Xian
    [J]. SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2022, 34 (03) : 1040 - 1048
  • [6] Survival after surgery in stage IA and IB non-small cell lung cancer
    Ost, David
    Goldberg, Judith
    Rolnitzky, Linda
    Rom, William N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (05) : 516 - 523
  • [7] The Prognostic Impact of Tumor Volume in Patients with Clinical Stage IA Non-Small Cell Lung Cancer
    Takenaka, Tomoyoshi
    Yamazaki, Koji
    Miura, Naoko
    Mori, Ryo
    Takeo, Sadanori
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : 1074 - 1080
  • [8] Comparison of Tumor Measurement Methods in Patients with Clinical Stage IA Non-Small Cell Lung Cancer
    Nagashima, T.
    Ito, H.
    Samejima, J.
    Osawa, J.
    Inafuku, K.
    Nito, M.
    Nakayama, H.
    Yamada, K.
    Yokose, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1980 - S1981
  • [9] Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer
    Park, Seong Yong
    Lee, Hyun-Sung
    Jang, Hee-Jin
    Lee, Geon Kook
    Chung, Kyung Young
    Zo, Jae Ill
    [J]. ANNALS OF THORACIC SURGERY, 2011, 91 (06): : 1668 - 1673
  • [10] Tumor size and survival in lung cancer, stage IA
    Lyons, Gustavo
    Quadrelli, Silvia
    Chimondegy, Domingo
    Iotti, Alejandro
    Silva, Carlos
    [J]. MEDICINA-BUENOS AIRES, 2008, 68 (01) : 23 - 30